Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Elan to Present at the Morgan Stanley Global Healthcare Unplugged Conference and Host Company Day
- DUBLIN, Ireland -- Elan Corporation, plc (NYSE: ELN) today announced that it will present at the Morgan Stanley Global Healthcare Unplugged Conference on Thursday, May 1, 2008 at 11:20am EDT in Miami, Florida. Interested parties may access a live audio web cast of the presentation by visiting the Investor Relations...
- Research articles 2008-04-18
- Elan Announces it will Present at the Goldman Sachs 28th Annual Global Healthcare Conference.
- M2 PRESSWIRE-25 May 2007-News Flash: Elan Announces it will Present at the Goldman Sachs 28th Annual Global Healthcare ConferenceC1994-2007 M2 COMMUNICATIONS LTD RDATE:25052007 Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a...
- Research articles 2007-05-25
- Pantry Intends to Offer Notes to Buyers: DHPI, PTRY, LDG, ELN, BIIB.
- M2 PRESSWIRE-15 November 2005-SessionsIR.com: Pantry Intends to Offer Notes to Buyers: DHPI, PTRY, LDG, ELN, BIIBC1994-2005 M2 COMMUNICATIONS LTD RDATE:15112005 Stocks in the News: Desert Health Products International Incorporated (OTC: DHPI), Pantry Incorporated (NASDAQ: PTRY), Longs Drug Stores Corporation (NYSE:...
- Research articles 2005-11-15
- Elan reveals favourable drug trials for key MS drug
- LONDON AFP — Irish pharmaceuticals giant Elan said that the latest tests on patients receiving its multiple sclerosis drug Tysabri resulted in no new cases of a rare and frequently fatal infection. Tysabri, made by the Irish drugs firm and US partner Biogen, was withdrawn in February after confirmed...
- Research articles 2005-10-17
- Elan Confirms SEC Probe
- O'Driscoll, Sean Irish Voice 04-19-2005 IRISH medical company Elan has confirmed that that it is being investigated by the Securities and Exchange Commission for possible insider trading. The investigation, confirmed by the corporation this week, follows complaints about alleged sales...
- Research articles 2005-04-19
- Elan Announces Completion of Offering of US$1.15 Billion Aggregate Principal Amount of Senior Notes
- DUBLIN, Ireland -- Elan Corporation, plc ("Elan") today announced that its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp., have completed the previously announced offering of US$1.15 billion aggregate principal amount of Senior Notes. Commenting on the completion of the offering, Shane Cooke, executive vice president...
- Research articles 2004-11-17
- Elan Reports Third Quarter 2004 Financial Results
- DUBLIN, Ireland -- Elan Corporation, plc today announced its third quarter 2004 results and provided a business update. Commenting on Elan's business, Kelly Martin, Elan's president and chief executive officer, said, "All of our energies are focused on delivering our science to patients with unmet medical needs. Today, our...
- Research articles 2004-10-28
- Merrill's Martin becomes CEO at Elan.
- Byline: Shanny Basar Kelly Martin, who was forced out at Merrill Lynch after Stan O'Neal took over at the bank has resurfaced at Elan, the Irish pharmaceuticals company under investigation by US regulators.O'Neal became chief executive at Merrill in December and restructured the ...
- Research articles 2003-01-07
- Elan appoints Merrill man to top job.
- Troubled Irish pharmaceutical company Elan has appointed an American banker to fill the vacant post of chief executive.Kelly Martin, most recently head of international brokerage at Merrill Lynch, said that he would not be moving to Dublin, where the company has its official headquarters. Instead, he...
- Research articles 2003-01-08
- Merrill linked to Elan royalty rights buyer.
- Merrill Lynch, one of Elan's investment bank advisers, was lead investor in a controversial company that acquired royalty rights to some of the troubled Irish pharmaceuticals group's products, it emerged on Thursday.Merrill is one of the main shareholders in Autoimmune Research and Development, one of two...
- Research articles 2002-07-19
- A new world order
- Peter Banyard examines Fitch's reasons for changing its ratings criteria. He then goes on to look at consumer credit, and considers that most uncommon of traits, common sense. It's usually a bit of a shaker whenever someone announces a new world order. Usually the best reaction is...
- Research articles 2002-05-01
- Elan.
- The Independent Elan, Ireland's biggest drugs company, is under investigation by the Securities and Exchange Commission SEC, over its controversial accounting practices. The company received a request for information from the SEC days after shocking the market with news of its...
- Research articles 2002-02-11
- Irish Pharmaceutical Firm Sees Drop in Price Following News of Investigation.
- Daily Mail, London Knight Ridder/Tribune Business News Feb. 9--Elan slumped again as the US Securities and Exchange Commission launched an investigation into claims the Irish drugs group used deceptive accounting policies. Elan's shares, UKpound 30 three weeks ago and UKpound 44.47 last year, fell...
- Research articles 2002-02-09
- Insurance costs surge.(benefits consulting firms)(Brief Article)(Illustration)(Statistical Data Included)(Directory)
- INDUSTRY TRENDS Premiums for employer-sponsored health insurance rose an average 11% in 2001, the largest increase in nearly a decade. Source: Kaiser Family Foundation and the Health Research and Educational Trust EMPLOYEE BENEFITS CONSULTANTS Ranked by Full-Time Professionals...
- Research articles 2001-12-01
- Brain Wave: Max Wallace aims to turn Cogent into a full-blown drug company -- and his most exciting hobby yet. (e - Carolina).(Cogent Neuroscience retreat at the Penland School of Crafts)
- The Penland School of Crafts, near Pisgah National Forest in Mitchell County, is one of the last places you'd expect the staff of a fledgling biotech company to go for a retreat. Mobile phones and pagers are frowned on. Computers are scarce. There's glassware, but hand-blown...
- Research articles 2001-12-01
- Gene Blues - United States Patent and Trademark Office overloaded - Industry Overview
- Is the Patent Office prepared to deal with the genomic revolution? IT'S EASY TO TRIP ON A YELLOW-AND-GREEN binder on the 12th floor of the United States Patent and Trademark Office's PTO biotechnology building. They're falling off the shelves, piled in corners, crowding every desk. Each represents a patent...
- Research articles 2001-04-01
- Emap Elan boosts its star power
- Looks, the Emap Elan style magazine aimed at women in their late teens to early twenties, is in the process of being revamped. The redesign is intended to attract a slightly older audience, while still retaining its regular readers. The title hopes to attract new readers through its increased...
- Research articles 2000-07-22
- Daily Mail, London, Market Report.
- Knight Ridder/Tribune Business News Jun. 19 -- JAPANESE GIVE EURO A BIG HELPING HAND: So the European Central Bank really can present a united front in support of the battered euro -- but it takes the Japanese to get things organised. Euro-zone...
- Research articles 1999-06-18
- ECHO Pipeline announces transporting of crude oil
- CALGARY, Alberta--BUSINESS WIRE--March 11, 1997--ELAN (TSE, ME:ELN.) ELAN Energy Inc. and Gibson Petroleum Company Limited announce the start-up of their recently constructed ECHO East Central Heavy Oil Pipeline. The 150 kilometer pipeline commenced transporting crude oil from the Elk Point, Alberta area to the Gibson Crude Oil...
- Research articles 1997-03-11
- Elan Energy Inc. and Gibson Petroleum Receive Pipeline Approval
- CALGARY, Alberta--BUSINESS WIRE--Sept. 18, 1996--ELAN ENERGY INC. (TSE, ME:ELN) ELAN Energy Inc. and Gibson Petroleum Company Limited today announced they have received regulatory approval to build a heavy oil pipeline from Elk Point, Alberta to Hardisty, Alberta.Construction is expected to commence in October, with an anticipated start-up date early in...
- Research articles 1996-09-18
- << Previous
- page 1 of 3
- Next >>
Content Types
Refining Tags
- Finance (15 results)
- Sales (9 results)
- Jim Edwards (8 results)
- Business Wire (8 results)
- Biogen Idec Inc. (7 results)
- SEC (6 results)
- Business Operations (5 results)
- Investment (5 results)
- Sales Strategy (4 results)
- Sales Force Management (3 results)
- Corporate Governance (3 results)
- Merrill Lynch & Co. Inc. (3 results)
- Corporate Law (3 results)
- Wyeth (3 results)
- Biotechnology (3 results)
- Investor (3 results)
